A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications
Condition: Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions: Drug: CCX168; Drug: Midazolam; Drug: Celecoxib; Drug: Itraconazole; Drug: Rifampicin Sponsor: Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials